A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to see if tetrabenazine, which is commonly used to
treat Huntington's Disease (HD), reduces the problems of impulsivity that are common in
patients with HD. Investigators will also see how the medicine affects aspects of thinking
and mood.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston William Ondo, MD